Antigen-test sensitivity depends on the population
A large hospital study illustrates why intended users, symptoms and study setting belong beside every performance estimate.
What was studied
Wagenhäuser and colleagues compared rapid antigen tests with RT-qPCR at a single German tertiary-care hospital between November 2020 and June 2023. Across 78,798 paired results, overall sensitivity was 34.5% and specificity was 99.6%. Higher viral load and typical COVID-19 symptoms were associated with a positive antigen result among infected individuals.
What the estimate does not say
The findings describe the tests, population and screening use in this study. They are not a universal sensitivity estimate for every rapid antigen product, symptomatic setting or specimen workflow. The authors associated the decline over time primarily with a changing symptom profile.
Implication for study planning
Our editorial takeaway is to define the intended population before choosing a performance target. Record symptoms, timing, comparator, specimen procedures and subgroup analyses so that the result can be interpreted in the context of intended use.
Sources & further reading
Read the original company post on LinkedInOriginal study — eBioMedicine, 2024PubMed abstract and bibliographic recordAdapted from a public company post, with sources checked on 8 October 2026. Original post dates are preserved; the website summary is not attributed to an individual employee.
